drugset / Trial / NCT00549497

A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers

NCT00549497

Phase 1 Completed 36 enrolled GlaxoSmithKline
NaSingle-groupDouble-blindTreatment

Summary

GW870086X is a novel inhaled steroid that has an improved safety profile over other steroids but is also less potent. This study will look at higher doses to confirm the improved safety profile.

Timeline

Start
2007-09
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject GW870086 Small molecule 6 mg Inhaled
Subject GW870086 Small molecule 12 mg Inhaled
Subject GW870086 Small molecule 15 mg Inhaled

Indications